Libidon — Khavinson bioregulator — prostate
Libidon is a polypeptide complex from bovine prostate tissue targeting prostate cells. Proposed to restore prostate epithelial gene expression programs, support prostate health, and reduce BPH progression. One small clinical study reported improved urinary symptoms in BPH patients.
Overview
This page is part of Hormonaly's evidence-graded compound library. All clinical claims are linked to peer-reviewed sources via our dual-layer citation verification pipeline.
Compound Class
Khavinson bioregulator — prostate
Mechanism of Action
Libidon is a polypeptide complex from bovine prostate tissue targeting prostate cells. Proposed to restore prostate epithelial gene expression programs, support prostate health, and reduce BPH progression. One small clinical study reported improved urinary symptoms in BPH patients.
Regulatory Status
Not FDA approved. Research peptide.
Evidence Level
Very Low — small clinical study published; data from Khavinson group only.